Dr. Lip Lee is a Consultant Clinical Oncologist with expertise in head and neck, lung, oesophageal, and skin cancer. He graduated from the University of Melbourne, Australia, in 1997, and then undertook general medical training in the UK. Dr. Lee began working in oncology in 2000 after completing his MRCP. During his training, Dr. Lee visited the MD Anderson Cancer Center and William Beaumont Maryland Proton Treatment Centre in the USA to develop further specific technical skills in IMRT, SABR, and Protons. He is one of the clinical leads who developed stereotactic lung radiotherapy for lung cancer for the first time in the North West, as well as proton therapy in head and neck patients. He has also been involved with new developments in VMAT (Volumetric Modulated Arc Therapy) for head and neck and lung cancers. He was on the examination panel for the Royal College of Radiologists, UK, and was the previous Training Programme Director for oncology training in the North West Region. Dr. Lee's research interests include intensity modulated radiotherapy (IMRT) treatment for head and neck cancer, image guided radiotherapy (IGRT), novel targeted agents for head and neck cancer including monoclonal antibodies, immunomodulators, immunotherapy, and live virus.